Dr. Carolyn Myers reports

FENDX ENGAGES GALENVS FOR PILOT SCALE-UP MANUFACTURING OF ITS LIQUID SURFACE COATING

Fendx Technologies Inc. has signed a statement of work (SOW) dated April 14, 2026, with Galenvs Sciences Inc., a Canadian contract manufacturing and service organization, to initiate pilot-scale manufacturing of Fendx's liquid surface coating.

Dr. Carolyn Myers, chief executive officer of Fendx, stated, "This pilot-scale project is an important step toward the commercialization of our new surface coating formulation, which has demonstrated promising anti-microbial activity and durability while offering a potentially streamlined pathway to commercial scale-up at a low cost of manufacturing." Dr. Myers continued, "This advancement in the development of our surface coating reinforces our commitment to innovation in hygiene and safety solutions."

The SOW will focus on establishing the manufacturing process of Fendx's liquid surface coating, with an emphasis on scalability and quality. The project will include the production of three independent lots that will then be evaluated by Fendx to ensure consistency and anti-microbial performance across the lots. This work is intended to assess manufacturability, process repeatability and lot-to-lot variability under controlled pilot-scale conditions and generate material suitable for internal evaluation, quality benchmarking and downstream third party testing.

The new liquid surface coating in development has demonstrated strong effectiveness against MRSA (Methicillin-resistant Staphylococcus aureus) and P. aeruginosa, along with encouraging durability for long-lasting protection. This advancement led to the filing of a provisional patent announced on Oct. 21, 2025, with Fendx as the assignee.

In addition, the company announces the termination of the collaboration agreement dated Jan. 20, 2026, and the memorandum of understanding dated Nov. 17, 2025, both with Aquaox LLC. The initial technical feasibility phase contemplated under the collaboration agreement was not feasible and the agreement was terminated, and, because this phase was foundational to the broader product development outlined in the MOU, the MOU was also terminated with the company providing a 30-day termination notice to Aquaox. The company will continue to focus on advancing its surface protection solutions already in development.

About Fendx Technologies Inc.

Fendx is a surface protection company developing innovative solutions to help reduce the spread of harmful pathogens in everyday environments. Leveraging proprietary technologies, the company is advancing a portfolio of protective surface coatings, including a liquid-based nanocoating technology and a specialized Foley catheter coating. The company is focused on building a robust intellectual property portfolio in the surface protection space and is committed to identifying and advancing new technologies and materials that enhance hygiene and safety across health care, consumer and commercial settings.

We seek Safe Harbor.